🇺🇸 FDA

Drug profile · INN

fosphenytoin sodium

CEREBYX

approved
US status
approved
Patents linked
0
News articles
0

Quick answer

fosphenytoin sodium (CEREBYX) is an FDA-listed pharmaceutical active ingredient. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: injection. Current US regulatory status: approved.

Key facts

INN fosphenytoin sodium
Brand CEREBYX
Route INJECTION
Formulation INJECTABLE

Frequently asked questions

What is fosphenytoin sodium?

fosphenytoin sodium (CEREBYX) is an FDA-listed pharmaceutical active ingredient. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: injection. Current US regulatory status: approved.

What is the brand name for fosphenytoin sodium?

CEREBYX is a marketed brand name for fosphenytoin sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of fosphenytoin sodium?

fosphenytoin sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.